Chris Morrison. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Anemia, Sickle Cell/drug therapyAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedClinical Trials, Phase II as TopicDrug Industry/economicsDrug Industry/organization & administrationHumans
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, Humanizedcrizanlizumab
Year: 2017 PMID: 28178263 DOI: 10.1038/nbt0217-106
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908